Recommendations for the use of immunoglobulin therapy for immunomodulation and antibody replacement

Peter, Jonny; Heckmann, Jeannine M; Novitzky, Nicolás

doi:10.7196/samj.8965

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion2

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

2020

Publication Types

Select...

Book2

Article1

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(2 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Adverse effects of IVIG can be classified as common (20 -40%), less common (<5%) and rare (<0.1%). [11] Fortunately, common reactions are usually mild, less common reactions are moderate in severity and severe reactions rarely occur. [11] Previous studies on maternal IVIG in Rh disease did not evaluate the maternal effects of this treatment.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Maternal intravenous immunoglobulin: A non-invasive treatment option for Rhesus D-sensitised women with previous adverse pregnancy outcomes

2020

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

“…[11] Fortunately, common reactions are usually mild, less common reactions are moderate in severity and severe reactions rarely occur. [11] Previous studies on maternal IVIG in Rh disease did not evaluate the maternal effects of this treatment. Among women who received IVIG in our study, there were no adverse maternal effects reported.…”

Section: Discussionmentioning

confidence: 99%